Bionomics Limited (BNOX)
USD 0.25
(4.59%)
USD 0.25
(4.59%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 17.89 Billion USD | 55813.68% |
| 2023 | 32 Million USD | 48.08% |
| 2022 | 21.61 Million USD | 81.29% |
| 2021 | 11.92 Million USD | 31.57% |
| 2020 | 9.06 Million USD | -52.76% |
| 2019 | 19.18 Million USD | 127.34% |
| 2018 | 8.43 Million USD | 32.49% |
| 2017 | 6.36 Million USD | -23.1% |
| 2016 | 8.28 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 2.6 Million USD | -84.86% |
| 2024 Q4 | 1.24 Million USD | 0.0% |
| 2024 Q2 | 13.74 Million USD | 428.09% |
| 2023 Q3 | 2.56 Million USD | -82.67% |
| 2023 Q1 | 1.87 Million USD | -51.84% |
| 2023 Q2 | 14.82 Million USD | 690.08% |
| 2023 FY | 9.02 Million USD | 9.01% |
| 2023 Q4 | 17.18 Million USD | 568.95% |
| 2022 Q4 | 3.89 Million USD | 0.0% |
| 2022 FY | 8.27 Million USD | 319.84% |
| 2022 Q2 | 4.61 Million USD | 0.0% |
| 2021 Q2 | 1.4 Million USD | 0.0% |
| 2021 Q4 | 7.14 Million USD | 0.0% |
| 2021 FY | 1.97 Million USD | 100.45% |
| 2020 FY | 983.71 Thousand USD | -60.25% |
| 2020 Q2 | 2.65 Million USD | 0.0% |
| 2020 Q4 | 3.56 Million USD | 0.0% |
| 2019 Q4 | 3 Million USD | 0.0% |
| 2019 FY | 2.47 Million USD | -70.67% |
| 2018 FY | 8.43 Million USD | 32.49% |
| 2017 FY | 6.36 Million USD | -23.1% |
| 2016 FY | 8.28 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AbCellera Biologics Inc. | 275.23 Million USD | -6400.834% |
| Alkermes plc | 996.24 Million USD | -1695.98% |
| Agenus Inc. | 78.18 Million USD | -22785.251% |
| Aptorum Group Limited | 10.56 Thousand USD | -169339063.354% |
| Ardelyx, Inc. | 169.93 Million USD | -10428.829% |
| Dyadic International, Inc. | 9.15 Million USD | -195387.494% |
| Eton Pharmaceuticals, Inc. | 22.25 Million USD | -80304.332% |
| Lantern Pharma Inc. | 17.87 Million USD | -99982.819% |
| Inhibikase Therapeutics, Inc. | 6.73 Million USD | -265683.197% |
| Novavax, Inc. | 779.12 Million USD | -2196.471% |
| Janux Therapeutics, Inc. | 81.06 Million USD | -21972.458% |
| Pyxis Oncology, Inc. | 82.19 Million USD | -21667.94% |
| TransCode Therapeutics, Inc. | 19.41 Million USD | -92040.8% |
| Ocuphire Pharma, Inc. | 29.6 Million USD | -60334.966% |
| Outlook Therapeutics, Inc. | 53.12 Million USD | -33578.89% |
| Madrigal Pharmaceuticals, Inc. | 380.49 Million USD | -4602.382% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -73511.16% |
| SELLAS Life Sciences Group, Inc. | 37.86 Million USD | -47148.082% |
| Syros Pharmaceuticals, Inc. | 30.77 Million USD | -58046.879% |
| Barinthus Biotherapeutics plc | 84.71 Million USD | -21020.421% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -102393.991% |
| Xeris Biopharma Holdings, Inc. | 168.43 Million USD | -10522.655% |
| Clearside Biomedical, Inc. | 32.71 Million USD | -54591.658% |
| C4 Therapeutics, Inc. | 159.78 Million USD | -11097.642% |
| Alnylam Pharmaceuticals, Inc. | 1.8 Billion USD | -893.987% |
| AlloVir, Inc. | 180.93 Million USD | -9788.951% |
| Arrowhead Pharmaceuticals, Inc. | 445.73 Million USD | -3914.111% |
| VYNE Therapeutics Inc. | 29.68 Million USD | -60180.224% |
| Bicycle Therapeutics plc | 216.92 Million USD | -8148.299% |
| BioXcel Therapeutics, Inc. | 171.9 Million USD | -10308.475% |
| ChromaDex Corporation | 56.37 Million USD | -31635.887% |
| Chimerix, Inc. | 93.38 Million USD | -19058.976% |
| Corbus Pharmaceuticals Holdings, Inc. | 13.9 Million USD | -128532.91% |
| Caribou Biosciences, Inc. | 150.53 Million USD | -11785.779% |
| CRISPR Therapeutics AG | 463.49 Million USD | -3760.325% |
| Precision BioSciences, Inc. | 92.46 Million USD | -19250.85% |
| Fate Therapeutics, Inc. | 254.04 Million USD | -6943.022% |
| Fortress Biotech, Inc. | 200.19 Million USD | -8837.474% |
| Fortress Biotech, Inc. | 200.19 Million USD | -8837.474% |
| HOOKIPA Pharma Inc. | 32.74 Million USD | -54539.883% |
| ImmuCell Corporation | 9.61 Million USD | -185942.451% |
| IDEAYA Biosciences, Inc. | 157.81 Million USD | -11237.635% |
| Immix Biopharma, Inc. | 16.14 Million USD | -110749.704% |
| Incyte Corporation | 1.19 Billion USD | -1402.936% |
| Innoviva, Inc. | 132.15 Million USD | -13439.035% |
| IO Biotech, Inc. | 91.44 Million USD | -19466.698% |
| Jaguar Health, Inc. | 42.01 Million USD | -42485.686% |
| Keros Therapeutics, Inc. | 169.27 Million USD | -10469.88% |
| Ligand Pharmaceuticals Incorporated | 84.32 Million USD | -21118.856% |
| ContextLogic Inc. | 387 Million USD | -4523.353% |
| MiMedx Group, Inc. | 229.72 Million USD | -7688.539% |
| MEI Pharma, Inc. | 34.78 Million USD | -51337.045% |
| NextCure, Inc. | 67.63 Million USD | -26353.533% |
| Onconetix, Inc. | 34.9 Million USD | -51156.641% |
| Oncternal Therapeutics, Inc. | 12.74 Million USD | -140276.4% |
| Opthea Limited | 191.96 Million USD | -9220.528% |
| Psyence Biomedical Ltd. | 2.75 Million USD | -650157.07% |
| Vaxcyte, Inc. | 468.04 Million USD | -3722.822% |
| PDS Biotechnology Corporation | 43.04 Million USD | -41466.451% |
| Precigen, Inc. | 84.18 Million USD | -21154.649% |
| Pharming Group N.V. | 225.49 Million USD | -7834.852% |
| Phathom Pharmaceuticals, Inc. | 167.82 Million USD | -10561.202% |
| Pieris Pharmaceuticals, Inc. | 72.56 Million USD | -24556.693% |
| PureTech Health plc | 144.59 Million USD | -12273.961% |
| Rigel Pharmaceuticals, Inc. | 130.26 Million USD | -13635.578% |
| Avidity Biosciences, Inc. | 245.15 Million USD | -7198.304% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -73511.16% |
| Sangamo Therapeutics, Inc. | 228.68 Million USD | -7724.198% |
| Sol-Gel Technologies Ltd. | 30.85 Million USD | -57881.062% |
| Acelyrin, Inc. | 422.06 Million USD | -4139.257% |
| Salarius Pharmaceuticals, Inc. | 12.89 Thousand USD | -138765031.069% |
| Summit Therapeutics Inc. | 87.68 Million USD | -20305.054% |
| Sensei Biotherapeutics, Inc. | 37.06 Million USD | -48174.272% |
| Senti Biosciences, Inc. | 94.7 Million USD | -18792.747% |
| Stoke Therapeutics, Inc. | 123.55 Million USD | -14381.539% |
| Elevation Oncology, Inc. | 45.44 Million USD | -39271.495% |
| Alaunos Therapeutics, Inc. | 29.46 Million USD | -60615.925% |
| Telomir Pharmaceuticals, Inc. Common Stock | 3.94 Million USD | -453785.29% |
| Entrada Therapeutics, Inc. | 132.17 Million USD | -13436.884% |
| VistaGen Therapeutics, Inc. | 34.08 Million USD | -52393.402% |
| Kintara Therapeutics, Inc. | 8.45 Million USD | -211619.039% |
| Wave Life Sciences Ltd. | 181.3 Million USD | -9768.879% |
| Seer, Inc. | 110.49 Million USD | -16093.661% |
| Verrica Pharmaceuticals Inc. | 70.59 Million USD | -25245.463% |
| Aadi Bioscience, Inc. | 93.47 Million USD | -19040.735% |
| ESSA Pharma Inc. | 32.13 Million USD | -55580.333% |
| GlycoMimetics, Inc. | 39.28 Million USD | -45444.718% |
| GT Biopharma, Inc. | 13.57 Million USD | -131694.166% |
| Inhibrx Biosciences, Inc. | 219.83 Million USD | -8039.188% |
| Akebia Therapeutics, Inc. | 201.11 Million USD | -8796.59% |
| Catalyst Pharmaceuticals, Inc. | 259.42 Million USD | -6796.936% |
| Longboard Pharmaceuticals, Inc. | 56.75 Million USD | -31423.417% |
| Orchestra BioMed Holdings, Inc. | 54.08 Million USD | -32985.015% |
| Alzamend Neuro, Inc. | 9.93 Million USD | -179946.44% |
| Sorrento Therapeutics, Inc. | 403.56 Million USD | -4333.602% |
| TRACON Pharmaceuticals, Inc. | 18.92 Million USD | -94423.62% |
| Viracta Therapeutics, Inc. | 50.69 Million USD | -35195.556% |
| Rocket Pharmaceuticals, Inc. | 259.65 Million USD | -6790.721% |
| Aptose Biosciences Inc. | 52.35 Million USD | -34074.452% |
| ZyVersa Therapeutics, Inc. | 14.41 Million USD | -124063.162% |
| Soligenix, Inc. | 7.79 Million USD | -229429.184% |
| Century Therapeutics, Inc. | 56.07 Million USD | -31810.214% |
| Kura Oncology, Inc. | 165.8 Million USD | -10691.281% |
| TScan Therapeutics, Inc. | 114.5 Million USD | -15525.574% |
| Intensity Therapeutics, Inc. | 8.31 Million USD | -214978.447% |
| Ocean Biomedical, Inc. | 2.48 Million USD | -720890.281% |
| CytomX Therapeutics, Inc. | 107.69 Million USD | -16513.471% |
| Autolus Therapeutics plc | 196.72 Million USD | -8995.074% |
| Mineralys Therapeutics, Inc. | 84.65 Million USD | -21035.141% |
| EyePoint Pharmaceuticals, Inc. | 116.45 Million USD | -15264.461% |
| Eterna Therapeutics Inc. | 19.38 Million USD | -92209.632% |
| Adaptive Biotechnologies Corporation | 321.75 Million USD | -5460.818% |
| GRI Bio, Inc. | 11.33 Million USD | -157820.353% |
| Xenetic Biosciences, Inc. | 7.05 Million USD | -253487.503% |
| Tenaya Therapeutics, Inc. | 131.19 Million USD | -13538.209% |
| IGM Biosciences, Inc. | 265.59 Million USD | -6636.816% |
| INmune Bio, Inc. | 29.89 Million USD | -59748.729% |
| Heron Therapeutics, Inc. | 172.55 Million USD | -10269.146% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -44282.195% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -111871.787% |
| Entero Therapeutics, Inc. | 15.74 Million USD | -113563.347% |
| Milestone Pharmaceuticals Inc. | 62.09 Million USD | -28713.128% |
| X4 Pharmaceuticals, Inc. | 107.52 Million USD | -16540.665% |
| Atara Biotherapeutics, Inc. | 275.69 Million USD | -6389.964% |
| Coherus BioSciences, Inc. | 301.45 Million USD | -5835.418% |
| Verastem, Inc. | 92.08 Million USD | -19330.494% |
| Abeona Therapeutics Inc. | 17.93 Million USD | -99640.091% |
| Pliant Therapeutics, Inc. | 185.72 Million USD | -9533.801% |
| Tonix Pharmaceuticals Holding Corp. | 121.4 Million USD | -14637.516% |
| Histogen Inc. | 14.27 Million USD | -125266.984% |
| Aprea Therapeutics, Inc. | 16.04 Million USD | -111391.885% |
| Surrozen, Inc. | 18.55 Million USD | -96354.857% |
| Organovo Holdings, Inc. | 14.91 Million USD | -119862.293% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -351403.86% |
| Ovid Therapeutics Inc. | 59.67 Million USD | -29883.96% |
| Panbela Therapeutics, Inc. | 25.64 Million USD | -69664.011% |
| CASI Pharmaceuticals, Inc. | 47 Million USD | -37964.026% |
| Cadrenal Therapeutics, Inc. Common Stock | 7.63 Million USD | -234312.997% |
| Centessa Pharmaceuticals plc | 178.13 Million USD | -9944.222% |
| Hepion Pharmaceuticals, Inc. | 48.44 Million USD | -36831.128% |
| Arcturus Therapeutics Holdings Inc. | 245 Million USD | -7202.891% |
| BioRestorative Therapies, Inc. | 15.36 Million USD | -116336.988% |
| Apollomics, Inc. | 54.14 Million USD | -32948.349% |
| Amarin Corporation plc | 272.35 Million USD | -6469.457% |
| Mesoblast Limited | 5.9 Million USD | -303057.845% |
| Turnstone Biologics Corp. | 78.33 Million USD | -22739.97% |
| Kymera Therapeutics, Inc. | 244.12 Million USD | -7229.276% |
| Synaptogenix, Inc. | 8.31 Million USD | -215111.573% |
| Tiziana Life Sciences Ltd | 14.58 Million USD | -122568.148% |
| Aurinia Pharmaceuticals Inc. | 253.05 Million USD | -6970.52% |
| BriaCell Therapeutics Corp. | 33.33 Million USD | -53582.374% |
| Monopar Therapeutics Inc. | 8.83 Million USD | -202503.328% |
| Exelixis, Inc. | 1.58 Billion USD | -1027.593% |
| Better Therapeutics, Inc. | 38.26 Million USD | -46662.783% |
| Nurix Therapeutics, Inc. | 232.05 Million USD | -7610.569% |
| Apellis Pharmaceuticals, Inc. | 855.2 Million USD | -1992.181% |
| NLS Pharmaceutics AG | 11.8 Million USD | -151439.6% |
| Dermata Therapeutics, Inc. | 8.04 Million USD | -222389.246% |
| Aridis Pharmaceuticals, Inc. | 29.99 Million USD | -59555.173% |
| Gritstone bio, Inc. | 148.37 Million USD | -11958.97% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -25883.323% |
| TNF Pharmaceuticals, Inc. | 16.36 Million USD | -109265.144% |
| Avid Bioservices, Inc. | 25.99 Million USD | -68727.42% |
| Insmed Incorporated | 949.26 Million USD | -1784.874% |
| Virpax Pharmaceuticals, Inc. | 15.68 Million USD | -113938.354% |
| MediWound Ltd. | 18.86 Million USD | -94729.213% |
| OmniAb, Inc. | 83.89 Million USD | -21227.107% |
| Alector, Inc. | 248.8 Million USD | -7091.412% |
| Seres Therapeutics, Inc. | 234.3 Million USD | -7536.263% |
| Checkpoint Therapeutics, Inc. | 52.25 Million USD | -34143.126% |
| Zai Lab Limited | 547.47 Million USD | -3168.157% |
| Revance Therapeutics, Inc. | 398.65 Million USD | -4388.197% |
| Aura Biosciences, Inc. | 84.99 Million USD | -20952.083% |
| Lyell Immunopharma, Inc. | 247.13 Million USD | -7139.832% |
| Immunic, Inc. | 99.22 Million USD | -17932.488% |
| Tarsus Pharmaceuticals, Inc. | 159.01 Million USD | -11152.217% |
| Veracyte, Inc. | 357.93 Million USD | -4898.806% |
| InMed Pharmaceuticals Inc. | 9.01 Billion USD | -98.457% |
| FibroGen, Inc. | 398.11 Million USD | -4394.296% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -125813.976% |
| Adial Pharmaceuticals, Inc. | 6.88 Million USD | -259663.555% |
| Sonnet BioTherapeutics Holdings, Inc. | 7.12 Million USD | -250995.27% |
| Jazz Pharmaceuticals plc | 3.25 Billion USD | -449.584% |
| Cyclacel Pharmaceuticals, Inc. | 25.87 Million USD | -69054.625% |
| Amylyx Pharmaceuticals, Inc. | 316.54 Million USD | -5552.431% |
| TG Therapeutics, Inc. | 198.47 Million USD | -8914.927% |
| Galecto, Inc. | 35.62 Million USD | -50121.394% |
| Calithera Biosciences, Inc. | 40.68 Million USD | -43873.497% |
| Fortrea Holdings Inc. | 457.3 Million USD | -3812.612% |
| KalVista Pharmaceuticals, Inc. | 54.27 Million USD | -32864.324% |
| Aptevo Therapeutics Inc. | 28.87 Million USD | -61858.501% |
| XBiotech Inc. | 37.51 Million USD | -47600.283% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -25883.323% |
| Lyra Therapeutics, Inc. | 20.64 Million USD | -86550.085% |
| Foghorn Therapeutics Inc. | 142.06 Million USD | -12494.854% |
| Y-mAbs Therapeutics, Inc. | 99.07 Million USD | -17959.426% |
| Theravance Biopharma, Inc. | 110.71 Million USD | -16060.606% |
| Ultragenyx Pharmaceutical Inc. | 958.24 Million USD | -1767.197% |
| Metagenomi, Inc. Common Stock | 28.84 Million USD | -61929.385% |
| Vaxxinity, Inc. | 56.05 Million USD | -31821.6% |
| BioCryst Pharmaceuticals, Inc. | 430.64 Million USD | -4054.834% |
| Gain Therapeutics, Inc. | 22.3 Million USD | -80104.971% |
| Cartesian Therapeutics, Inc. | 110.86 Million USD | -16038.595% |
| NexImmune, Inc. | 28.16 Million USD | -63421.327% |
| Creative Medical Technology Holdings, Inc. | 5.53 Million USD | -323395.647% |
| Marker Therapeutics, Inc. | 17.89 Million USD | -99899.245% |
| Regeneron Pharmaceuticals, Inc. | 2.81 Billion USD | -535.541% |
| Chemomab Therapeutics Ltd. | 25.45 Million USD | -70179.178% |
| Scopus BioPharma Inc. | 11.71 Million USD | -152632.086% |
| RAPT Therapeutics, Inc. | 127.06 Million USD | -13981.611% |
| Ainos, Inc. | 12.95 Million USD | -138036.66% |
| Pluri Inc. | 22.48 Million USD | -79492.42% |
| Prothena Corporation plc | 282.4 Million USD | -6235.693% |
| Adaptimmune Therapeutics plc | 200.02 Million USD | -8845.204% |
| Celularity Inc. | 215.05 Million USD | -8219.791% |
| Rallybio Corporation | 78.93 Million USD | -22568.089% |
| Cue Biopharma, Inc. | 19.54 Million USD | -91458.571% |
| MeiraGTx Holdings plc | 151.07 Million USD | -11743.138% |
| Omeros Corporation | 94.75 Million USD | -18783.575% |
| Humacyte, Inc. | 23.49 Million USD | -76047.491% |
| Immunocore Holdings plc | 308.04 Million USD | -5708.459% |
| Cocrystal Pharma, Inc. | 3.39 Million USD | -527698.702% |
| Cidara Therapeutics, Inc. | 86.86 Million USD | -20497.912% |
| Blueprint Medicines Corporation | 722.86 Million USD | -2375.217% |
| CalciMedica, Inc. | 21.81 Million USD | -81911.166% |
| Cabaletta Bio, Inc. | 74.66 Million USD | -23865.143% |
| Marinus Pharmaceuticals, Inc. | 160.54 Million USD | -11045.12% |
| Scholar Rock Holding Corporation | 171.29 Million USD | -10345.358% |
| Sana Biotechnology, Inc. | 294.94 Million USD | -5966.446% |
| Pulmatrix, Inc. | 22.03 Million USD | -81088.747% |
| Elicio Therapeutics, Inc. | 34.57 Million USD | -51649.461% |
| Vigil Neuroscience, Inc. | 88.86 Million USD | -20034.108% |
| Intellia Therapeutics, Inc. | 551.56 Million USD | -3143.923% |
| Adlai Nortye Ltd. American Depositary Shares | 72.55 Million USD | -24561.791% |
| Cytokinetics, Incorporated | 173.61 Million USD | -10205.956% |
| Eloxx Pharmaceuticals, Inc. | 34.41 Million USD | -51884.009% |
| Nutriband Inc. | 5.73 Million USD | -311938.355% |
| Protara Therapeutics, Inc. | 43.61 Million USD | -40925.327% |
| Vor Biopharma Inc. | 126.03 Million USD | -14096.242% |
| Roivant Sciences Ltd. | 1.18 Billion USD | -1404.599% |
| Evogene Ltd. | 27.79 Million USD | -64284.225% |
| ProKidney Corp. | 151.52 Million USD | -11708.434% |
| Applied Therapeutics, Inc. | 74.17 Million USD | -24021.842% |
| Hoth Therapeutics, Inc. | 7.69 Million USD | -232502.874% |
| BridgeBio Pharma, Inc. | 614.22 Million USD | -2812.991% |
| CorMedix Inc. | 48.95 Million USD | -36446.537% |
| BioLineRx Ltd. | 50.8 Million USD | -35119.826% |
| Tango Therapeutics, Inc. | 150.7 Million USD | -11772.844% |
| Galectin Therapeutics Inc. | 38.07 Million USD | -46896.155% |
| Atai Life Sciences N.V. | 125.78 Million USD | -14124.57% |
| Renovaro Biosciences Inc. | 81.63 Million USD | -21816.377% |
| Aerovate Therapeutics, Inc. | 81.4 Million USD | -21878.376% |
| Zentalis Pharmaceuticals, Inc. | 252.55 Million USD | -6984.63% |
| Sagimet Biosciences Inc. | 32.74 Million USD | -54549.896% |
| MediciNova, Inc. | 10.9 Million USD | -164046.248% |
| Praxis Precision Medicines, Inc. | 128.82 Million USD | -13789.44% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -246367.62% |
| GeoVax Labs, Inc. | 6.02 Million USD | -297008.303% |
| Axsome Therapeutics, Inc. | 476.36 Million USD | -3656.062% |
| Biomea Fusion, Inc. | 126.13 Million USD | -14085.1% |
| PTC Therapeutics, Inc. | 1.31 Billion USD | -1263.917% |
| Mereo BioPharma Group plc | 35.84 Million USD | -49820.138% |
| Cullinan Oncology, Inc. | 191.08 Million USD | -9263.373% |
| Syndax Pharmaceuticals, Inc. | 229.95 Million USD | -7680.85% |
| Absci Corporation | 73.66 Million USD | -24188.513% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -64769.756% |
| 4D Molecular Therapeutics, Inc. | 133.59 Million USD | -13293.5% |
| Dyne Therapeutics, Inc. | 242.16 Million USD | -7288.598% |
| Kiniksa Pharmaceuticals, Ltd. | 262.04 Million USD | -6727.9% |
| Ventyx Biosciences, Inc. | 207.99 Million USD | -8502.352% |
| Allakos Inc. | 196.05 Million USD | -9026.156% |
| Imunon, Inc. | 20.31 Million USD | -87994.543% |
| Fulcrum Therapeutics, Inc. | 113.46 Million USD | -15668.515% |
| Corcept Therapeutics Incorporated | 368.61 Million USD | -4753.986% |
| BioAtla, Inc. | 129.68 Million USD | -13696.584% |
| NLS Pharmaceutics AG | 11.8 Million USD | -151439.6% |
| Bio-Path Holdings, Inc. | 15.84 Million USD | -112835.53% |
| Allogene Therapeutics, Inc. | 84.91 Million USD | -20970.181% |
| Larimar Therapeutics, Inc. | 41.75 Million USD | -42747.78% |
| XOMA Corporation | 46.46 Million USD | -38408.869% |
| Kezar Life Sciences, Inc. | 111.17 Million USD | -15994.463% |
| Cara Therapeutics, Inc. | 142.46 Million USD | -12459.314% |
| aTyr Pharma, Inc. | 12.97 Million USD | -137756.353% |
| Aligos Therapeutics, Inc. | 103.65 Million USD | -17161.303% |
| Akero Therapeutics, Inc. | 172.87 Million USD | -10250.191% |
| Viridian Therapeutics, Inc. | 254.76 Million USD | -6923.118% |
| Eliem Therapeutics, Inc. | 37.4 Million USD | -47730.346% |
| EyeGate Pharmaceuticals, Inc. | 8.22 Million USD | -217441.406% |
| Akari Therapeutics, Plc | 16.8 Million USD | -106364.215% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -786734.303% |
| Halozyme Therapeutics, Inc. | 299.31 Million USD | -5877.715% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -265810.149% |
| UroGen Pharma Ltd. | 138.88 Million USD | -12782.593% |
| Sutro Biopharma, Inc. | 243 Million USD | -7262.845% |
| ZIVO Bioscience, Inc. | 7.27 Million USD | -245856.092% |
| Orgenesis Inc. | 45.75 Million USD | -39003.036% |
| Entera Bio Ltd. | 8.86 Million USD | -201845.553% |
| GH Research PLC | 41.22 Million USD | -43304.92% |
| Lisata Therapeutics, Inc. | 25.7 Million USD | -69498.475% |
| Reneo Pharmaceuticals, Inc. | 83.05 Million USD | -21443.323% |
| Xencor, Inc. | 306.97 Million USD | -5728.572% |
| 60 Degrees Pharmaceuticals, Inc. | 4.93 Million USD | -362563.253% |
| Replimune Group, Inc. | 234.77 Million USD | -7521.139% |
| Coeptis Therapeutics Holdings, Inc. | 20.48 Million USD | -87222.957% |
| Vanda Pharmaceuticals Inc. | 191.79 Million USD | -9228.858% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -265810.149% |
| Portage Biotech Inc. | 18.19 Million USD | -98215.16% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -246367.62% |
| Olema Pharmaceuticals, Inc. | 104.96 Million USD | -16946.69% |
| OncoCyte Corporation | 25.63 Million USD | -69691.224% |
| Qualigen Therapeutics, Inc. | 6.09 Million USD | -293429.028% |
| Processa Pharmaceuticals, Inc. | 11.45 Million USD | -156068.986% |
| Purple Biotech Ltd. | -22.46 Million USD | 79738.474% |
| CollPlant Biotechnologies Ltd. | 16.48 Million USD | -108470.243% |
| scPharmaceuticals Inc. | 65.17 Million USD | -27351.557% |
| ProMIS Neurosciences, Inc. | 8.45 Million USD | -211575.557% |
| HilleVax, Inc. | 133.34 Million USD | -13318.108% |
| NeuroSense Therapeutics Ltd. | 10.28 Million USD | -173865.737% |
| Tharimmune, Inc. | 9.45 Million USD | -189132.784% |
| Genprex, Inc. | 31.06 Million USD | -57504.797% |
| Neumora Therapeutics, Inc. Common Stock | 187.52 Million USD | -9441.277% |
| Atossa Therapeutics, Inc. | 31.37 Million USD | -56923.858% |
| XTL Biopharmaceuticals Ltd. | 765 Thousand USD | -2338772.68% |
| Virios Therapeutics, Inc. | 5.44 Million USD | -328386.177% |
| OKYO Pharma Limited | 8243.57 USD | -217046349.536% |
| Savara Inc. | 15.74 Million USD | -113538.463% |
| Curis, Inc. | 58.35 Million USD | -30561.256% |
| Daré Bioscience, Inc. | 33.6 Million USD | -53136.222% |
| Carmell Therapeutics Corporation | 5.09 Million USD | -351248.418% |
| Titan Pharmaceuticals, Inc. | 7.46 Million USD | -239712.036% |
| Achieve Life Sciences, Inc. | 27.02 Million USD | -66114.107% |
| BeiGene, Ltd. | 3.28 Billion USD | -444.405% |
| Kiromic BioPharma, Inc. | 19.93 Million USD | -89634.223% |
| Revolution Medicines, Inc. Warrant | 498.76 Million USD | -3487.336% |
| Protagonist Therapeutics, Inc. | 153.65 Million USD | -11544.74% |
| Erasca, Inc. | 141.52 Million USD | -12542.555% |
| bluebird bio, Inc. | 240.23 Million USD | -7347.957% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -395139.204% |
| BioMarin Pharmaceutical Inc. | 1.74 Billion USD | -924.602% |
| DBV Technologies S.A. | 92.16 Million USD | -19314.47% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -395139.204% |
| Moderna, Inc. | 6.39 Billion USD | -179.831% |
| Vincerx Pharma, Inc. | 42.6 Million USD | -41892.011% |
| Fresh Tracks Therapeutics, Inc. | 14.36 Million USD | -124446.68% |
| Molecular Templates, Inc. | 63.09 Million USD | -28259.633% |
| Acrivon Therapeutics, Inc. Common Stock | 66.7 Million USD | -26724.75% |
| Travere Therapeutics, Inc. | 472 Million USD | -3690.742% |
| Monte Rosa Therapeutics, Inc. | 143.31 Million USD | -12384.998% |
| Spruce Biosciences, Inc. | 62.08 Million USD | -28720.553% |
| Celldex Therapeutics, Inc. | 43.41 Million USD | -41113.378% |
| Cogent Biosciences, Inc. | 208.13 Million USD | -8496.731% |
| MacroGenics, Inc. | 217.21 Million USD | -8137.173% |
| RenovoRx, Inc. | 11.39 Million USD | -156905.756% |
| Adicet Bio, Inc. | 152.03 Million USD | -11668.358% |
| Prime Medicine, Inc. | 186.63 Million USD | -9486.622% |
| Aditxt, Inc. | 25.95 Million USD | -68847.393% |
| Adagene Inc. | 41.83 Million USD | -42672.641% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -244662.464% |
| Quantum-Si incorporated | 111.65 Million USD | -15924.123% |
| Maravai LifeSciences Holdings, Inc. | 171.85 Million USD | -10311.624% |
| Acurx Pharmaceuticals, Inc. | 14.57 Million USD | -122637.418% |
| Voyager Therapeutics, Inc. | 35.82 Million USD | -49848.01% |
| SciSparc Ltd. | 9.01 Million USD | -198461.492% |
| Vericel Corporation | 142.04 Million USD | -12496.716% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -206589.043% |
| Minerva Neurosciences, Inc. | 23.08 Million USD | -77394.437% |
| Generation Bio Co. | 144.46 Million USD | -12285.096% |
| Astria Therapeutics, Inc. | 83.03 Million USD | -21449.291% |
| Black Diamond Therapeutics, Inc. | 86.46 Million USD | -20594.397% |
| Arcutis Biotherapeutics, Inc. | 295.72 Million USD | -5950.445% |
| Invivyd, Inc. | 205.75 Million USD | -8595.962% |
| Relay Therapeutics, Inc. | 72.15 Million USD | -24695.765% |
| Quoin Pharmaceuticals, Ltd. | 9.37 Million USD | -190680.704% |
| Spero Therapeutics, Inc. | 75.25 Million USD | -23675.98% |
| Artelo Biosciences, Inc. | 10.28 Million USD | -173831.914% |
| 2seventy bio, Inc. | 289.88 Million USD | -6072.19% |
| ADMA Biologics, Inc. | 66.58 Million USD | -26771.078% |
| Clene Inc. | 41.07 Million USD | -43462.379% |
| Capricor Therapeutics, Inc. | 12.8 Million USD | -139598.12% |
| Boundless Bio, Inc. Common Stock | 54.79 Million USD | -32552.705% |
| GeoVax Labs, Inc. | 6.02 Million USD | -297008.303% |
| Recursion Pharmaceuticals, Inc. | 352.04 Million USD | -4982.368% |
| Citius Pharmaceuticals, Inc. | 36.73 Million USD | -48610.572% |
| Contineum Therapeutics, Inc. Class A Common Stock | 33.72 Million USD | -52949.028% |
| Relmada Therapeutics, Inc. | 103.7 Million USD | -17153.646% |
| Finch Therapeutics Group, Inc. | 32.58 Million USD | -54803.115% |
| ALX Oncology Holdings Inc. | 170.27 Million USD | -10407.744% |
| Vir Biotechnology, Inc. | 767.72 Million USD | -2230.586% |
| Evaxion Biotech A/S | 22.27 Million USD | -80242.955% |
| Ocular Therapeutix, Inc. | 135.54 Million USD | -13100.419% |
| Verve Therapeutics, Inc. | 234.88 Million USD | -7517.602% |
| Trevena, Inc. | 38.41 Million USD | -46478.96% |
| Surrozen, Inc. | 18.55 Million USD | -96354.857% |
| Tyra Biosciences, Inc. | 79.94 Million USD | -22280.857% |
| Cingulate Inc. | 22.75 Million USD | -78516.053% |
| Galmed Pharmaceuticals Ltd. | -7.49 Million USD | 238919.754% |
| Unity Biotechnology, Inc. | 44.66 Million USD | -39957.259% |
| Tenax Therapeutics, Inc. | 8.23 Million USD | -217200.27% |
| Terns Pharmaceuticals, Inc. | 102.55 Million USD | -17346.105% |
| ACADIA Pharmaceuticals Inc. | 754.08 Million USD | -2272.727% |
| Connect Biopharma Holdings Limited | 62.07 Million USD | -28724.268% |
| Clearmind Medicine Inc. | 8.74 Million USD | -204586.645% |
| Kronos Bio, Inc. | 128.11 Million USD | -13865.544% |
| Bolt Biotherapeutics, Inc. | 84.07 Million USD | -21182.206% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -609939.806% |
| Viking Therapeutics, Inc. | 100.82 Million USD | -17645.62% |
| Statera Biopharma, Inc. | 28.82 Million USD | -61962.721% |
| ImmunityBio, Inc. | 362.87 Million USD | -4830.768% |
| Korro Bio, Inc. | 84.53 Million USD | -21065.893% |
| Kineta, Inc. | 21.15 Million USD | -84473.53% |
| BioVie Inc. | 31.95 Million USD | -55900.812% |
| Codexis, Inc. | 66.51 Million USD | -26798.548% |
| Celularity Inc. | 215.05 Million USD | -8219.791% |
| Crinetics Pharmaceuticals, Inc. | 226.62 Million USD | -7795.286% |
| Celcuity Inc. | 66.23 Million USD | -26915.381% |
| Virax Biolabs Group Limited | 6.54 Million USD | -273188.588% |
| Cibus, Inc. | 320.3 Million USD | -5486.043% |
| Eledon Pharmaceuticals, Inc. | 43 Million USD | -41510.177% |
| eFFECTOR Therapeutics, Inc. | 33.84 Million USD | -52767.202% |
| IN8bio, Inc. | 30.33 Million USD | -58878.726% |
| Kodiak Sciences Inc. | 277.32 Million USD | -6351.865% |
| Annexon, Inc. | 143.72 Million USD | -12349.209% |
| Adverum Biotechnologies, Inc. | 127.59 Million USD | -13923.227% |
| Assembly Biosciences, Inc. | 22.9 Million USD | -78001.951% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -2795583.75% |
| Ionis Pharmaceuticals, Inc. | 779.58 Million USD | -2195.11% |
| Eyenovia, Inc. | 25.4 Million USD | -70324.553% |
| Puma Biotechnology, Inc. | 140.31 Million USD | -12651.578% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -321589.608% |
| Xilio Therapeutics, Inc. | 79.13 Million USD | -22510.511% |
| Arcellx, Inc. | 200.19 Million USD | -8837.295% |
| Cardiff Oncology, Inc. | 45.9 Million USD | -38881.211% |
| Enanta Pharmaceuticals, Inc. | 216.41 Million USD | -8167.776% |
| Regulus Therapeutics Inc. | 9.95 Million USD | -179596.455% |
| Moolec Science SA | 52.75 Million USD | -33818.806% |
| Acumen Pharmaceuticals, Inc. | 61.13 Million USD | -29165.557% |
| Geron Corporation | 70.44 Million USD | -25300.514% |
| LAVA Therapeutics N.V. | 46.54 Million USD | -38345.157% |
| Royalty Pharma plc | 862.4 Million USD | -1974.709% |
| Atea Pharmaceuticals, Inc. | 94.07 Million USD | -18919.874% |
| Greenwich LifeSciences, Inc. | 9.32 Million USD | -191716.392% |
| TFF Pharmaceuticals, Inc. | 22.62 Million USD | -78969.978% |
| Mersana Therapeutics, Inc. | 207.81 Million USD | -8509.886% |
| Humacyte, Inc. | 23.49 Million USD | -76047.491% |
| Structure Therapeutics Inc. | 102.77 Million USD | -17309.269% |
| 89bio, Inc. | 151.2 Million USD | -11733.269% |
| PMV Pharmaceuticals, Inc. | 80.13 Million USD | -22228.628% |
| Avenue Therapeutics, Inc. | 14.54 Million USD | -122956.231% |
| Genelux Corporation | 24.33 Million USD | -73425.276% |
| Trevi Therapeutics, Inc. | 33.92 Million USD | -52644.085% |
| Lexicon Pharmaceuticals, Inc. | 172.86 Million USD | -10250.251% |
| Notable Labs, Ltd. | 14.77 Million USD | -121039.986% |
| Liquidia Corporation | 87.98 Million USD | -20235.943% |
| Mustang Bio, Inc. | 48.5 Million USD | -36790.736% |
| Immunovant, Inc. | 282.7 Million USD | -6228.902% |
| Quantum-Si incorporated | 111.65 Million USD | -15924.123% |
| Arbutus Biopharma Corporation | 22.54 Million USD | -79266.466% |
| DiaMedica Therapeutics Inc. | 21.26 Million USD | -84032.111% |
| Vera Therapeutics, Inc. | 102.01 Million USD | -17439.482% |
| Acasti Pharma Inc. | 11.3 Million USD | -158225.6% |
| MiNK Therapeutics, Inc. | 22.92 Million USD | -77960.704% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -111871.787% |
| Xenon Pharmaceuticals Inc. | 46.54 Million USD | -38343.505% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -1576904.354% |
| NeuroBo Pharmaceuticals, Inc. | 15.88 Million USD | -112529.838% |
| Tempest Therapeutics, Inc. | 29.15 Million USD | -61265.627% |
| Soleno Therapeutics, Inc. | 41.38 Million USD | -43135.009% |
| PepGen Inc. | 84.76 Million USD | -21007.963% |
| Moleculin Biotech, Inc. | 29.63 Million USD | -60283.976% |
| United Therapeutics Corporation | 885.1 Million USD | -1921.509% |
| Nuvectis Pharma, Inc. | 22.89 Million USD | -78042.883% |
| Solid Biosciences Inc. | 104.31 Million USD | -17052.256% |
| BriaCell Therapeutics Corp. | 32.72 Million USD | -54574.054% |
| Immuneering Corporation | 58.41 Million USD | -30530.871% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -351403.86% |
| Silo Pharma, Inc. | 3.92 Million USD | -456122.156% |
| Belite Bio, Inc | 31.66 Million USD | -56399.861% |
| XOMA Corporation | 46.46 Million USD | -38408.869% |
| ARS Pharmaceuticals, Inc. | 67.55 Million USD | -26387.603% |
| Apogee Therapeutics, Inc. | 93 Million USD | -19138.493% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 50246.794% |
| uniQure N.V. | 285.08 Million USD | -6176.133% |
| Cassava Sciences, Inc. | 105.95 Million USD | -16786.45% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -244662.464% |
| Poseida Therapeutics, Inc. | 194.2 Million USD | -9113.044% |
| Forte Biosciences, Inc. | 32.47 Million USD | -54992.455% |
| Anebulo Pharmaceuticals, Inc. | 8.3 Million USD | -215243.647% |
| Enlivex Therapeutics Ltd. | 29.39 Million USD | -60768.774% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -321589.608% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -125813.976% |
| FibroBiologics, Inc. Common Stock | 8.88 Million USD | -201186.714% |
| Altimmune, Inc. | 30.55 Million USD | -58456.015% |
| Amicus Therapeutics, Inc. | 427.65 Million USD | -4083.873% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 50246.794% |
| Compugen Ltd. | 43.97 Million USD | -40591.31% |
| Peak Bio, Inc. | 1249.13 USD | -1432386921.367% |
| Zevra Therapeutics, Inc. | 74.12 Million USD | -24039.741% |
| Benitec Biopharma Inc. | 22.38 Million USD | -79840.917% |
| Spyre Therapeutics, Inc. | 243.18 Million USD | -7257.395% |
| NKGen Biotech, Inc. Common Stock | 28.54 Million USD | -62585.688% |
| Zura Bio Limited | 62.63 Million USD | -28464.731% |
| PolyPid Ltd. | 21.04 Million USD | -84919.606% |
| Aileron Therapeutics, Inc. | 16.27 Million USD | -109831.04% |
| NKGen Biotech, Inc. Warrants | 28.54 Million USD | -62585.688% |
| Instil Bio, Inc. | 85.78 Million USD | -20757.231% |
| argenx SE | 1.53 Billion USD | -1066.744% |
| Immunome, Inc. | 122.82 Million USD | -14467.966% |
| Compass Therapeutics, Inc. | 48.47 Million USD | -36812.046% |
| Verona Pharma plc | 67.15 Million USD | -26544.878% |
| enGene Holdings Inc. Warrants | 25.88 Million USD | -69022.565% |
| Shattuck Labs, Inc. | 93.61 Million USD | -19012.928% |
| CervoMed Inc. | 14.95 Million USD | -119519.299% |
| LENZ Therapeutics, Inc. | 70.7 Million USD | -25206.389% |
| Plus Therapeutics, Inc. | 8.54 Million USD | -209314.513% |
| Dianthus Therapeutics, Inc. | 51 Million USD | -34983.09% |
| Moolec Science SA | 52.75 Million USD | -33818.806% |
| Enveric Biosciences, Inc. | 16.44 Million USD | -108678.559% |
| Inovio Pharmaceuticals, Inc. | 132.55 Million USD | -13398.064% |
| AnaptysBio, Inc. | 181.56 Million USD | -9754.366% |
| Design Therapeutics, Inc. | 78.19 Million USD | -22783.202% |
| Leap Therapeutics, Inc. | 87.04 Million USD | -20456.262% |
| NeurAxis, Inc. | 8.82 Million USD | -202733.832% |
| Seelos Therapeutics, Inc. | 12.58 Million USD | -142072.237% |
| Lumos Pharma, Inc. | 38.66 Million USD | -46175.381% |
| Achilles Therapeutics plc | 75.25 Million USD | -23675.664% |
| enGene Holdings Inc. Common Stock | 25.88 Million USD | -69022.565% |
| 180 Life Sciences Corp. | 13.47 Million USD | -132657.381% |
| Opiant Pharmaceuticals, Inc. | 26.5 Million USD | -67412.179% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -609939.806% |
| Nutriband Inc. | 5.73 Million USD | -311938.355% |
| ORIC Pharmaceuticals, Inc. | 110.78 Million USD | -16051.269% |
| CG Oncology, Inc. Common stock | 55.65 Million USD | -32049.886% |
| Fractyl Health, Inc. Common Stock | 50.87 Million USD | -35066.524% |
| Rani Therapeutics Holdings, Inc. | 66.09 Million USD | -26969.057% |
| MoonLake Immunotherapeutics | 54.12 Million USD | -32958.671% |
| Palisade Bio, Inc. | 13.32 Million USD | -134227.147% |
| Tourmaline Bio, Inc. | 45.4 Million USD | -39302.709% |
| Beam Therapeutics Inc. | 554.19 Million USD | -3128.54% |
| Neurogene Inc. | 55.58 Million USD | -32090.375% |
| Mirum Pharmaceuticals, Inc. | 248.48 Million USD | -7100.47% |
| AEON Biopharma, Inc. | 48.42 Million USD | -36845.582% |
| CARGO Therapeutics, Inc. Common Stock | 96.71 Million USD | -18401.061% |
| Sesen Bio, Inc. | 78.38 Million USD | -22727.44% |
| Enliven Therapeutics, Inc. | 83.52 Million USD | -21320.556% |
| Kiora Pharmaceuticals, Inc. | 12.58 Million USD | -142050.821% |
| Iovance Biotherapeutics, Inc. | 450.99 Million USD | -3867.329% |
| Taysha Gene Therapies, Inc. | 87.89 Million USD | -20257.693% |
| Athira Pharma, Inc. | 125.46 Million USD | -14160.737% |
| Vaccinex, Inc. | 23.45 Million USD | -76183.846% |
| HCW Biologics Inc. | 21.02 Million USD | -84990.282% |
| XOMA Corporation | 46.46 Million USD | -38408.869% |
| Nektar Therapeutics | 190.9 Million USD | -9272.496% |
| Arvinas, Inc. | 480 Million USD | -3627.578% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -786734.303% |
| Merus N.V. | 200.49 Million USD | -8824.145% |
| Omega Therapeutics, Inc. | 103.35 Million USD | -17211.573% |
| Quince Therapeutics, Inc. | 34.62 Million USD | -51582.195% |
| Rezolute, Inc. | 70.38 Million USD | -25320.001% |
| Clene Inc. | 41.07 Million USD | -43462.379% |
| Indaptus Therapeutics, Inc. | 16.37 Million USD | -109143.242% |
| BeyondSpring Inc. | 24.86 Million USD | -71858.078% |
| Synlogic, Inc. | 58.53 Million USD | -30468.537% |
| Allarity Therapeutics, Inc. | 17.89 Million USD | -99902.101% |
| Phio Pharmaceuticals Corp. | 4.49 Million USD | -398216.474% |
| Peak Bio, Inc. | 1249.13 USD | -1432386921.367% |
| Werewolf Therapeutics, Inc. | 60.44 Million USD | -29500.596% |
| Krystal Biotech, Inc. | 160.42 Million USD | -11053.04% |
| Karyopharm Therapeutics Inc. | 270.63 Million USD | -6511.355% |
| SpringWorks Therapeutics, Inc. | 348.03 Million USD | -5040.926% |
| Lipella Pharmaceuticals Inc. | 2.15 Million USD | -829505.134% |
| MannKind Corporation | 125.59 Million USD | -14145.863% |
| Ikena Oncology, Inc. | 84.57 Million USD | -21055.132% |
| Cyclerion Therapeutics, Inc. | 9.64 Million USD | -185370.882% |
| Gyre Therapeutics, Inc. | 89.6 Million USD | -19868.947% |
| Gossamer Bio, Inc. | 183.75 Million USD | -9636.871% |
| CohBar, Inc. | 12.38 Million USD | -144329.666% |
| Cognition Therapeutics, Inc. | 50.72 Million USD | -35173.985% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -64769.756% |
| Legend Biotech Corporation | 583.14 Million USD | -2968.255% |
| Mural Oncology plc | 192.07 Million USD | -9215.501% |
| Biora Therapeutics, Inc. | 67.14 Million USD | -26546.575% |
| PaxMedica, Inc. Common Stock | 16.14 Million USD | -110721.156% |
| Disc Medicine, Inc. | 91.12 Million USD | -19534.981% |
| Champions Oncology, Inc. | 28.11 Million USD | -63551.284% |
| REGENXBIO Inc. | 321.15 Million USD | -5471.224% |
| Ensysce Biosciences, Inc. | 5.36 Million USD | -333636.151% |
| Anavex Life Sciences Corp. | 55.75 Million USD | -31990.494% |
| Cellectar Biosciences, Inc. | 38.96 Million USD | -45824.232% |
| Edgewise Therapeutics, Inc. | 114.35 Million USD | -15546.07% |
| Vaxart, Inc. | 90.72 Million USD | -19621.332% |
| PharmaCyte Biotech, Inc. | 8.52 Million USD | -209904.216% |
| Aldeyra Therapeutics, Inc. | 42.79 Million USD | -41710.397% |
| Cellectis S.A. | 97.32 Million USD | -18285.097% |
| Longeveron Inc. | 21.25 Million USD | -84099.416% |
| Repare Therapeutics Inc. | 167.35 Million USD | -10591.143% |
| Sarepta Therapeutics, Inc. | 1.36 Billion USD | -1214.826% |
| Inozyme Pharma, Inc. | 75.64 Million USD | -23553.085% |
| Revolution Medicines, Inc. | 498.76 Million USD | -3487.336% |
| Nymox Pharmaceutical Corporation | 6.65 Million USD | -268877.39% |
| Third Harmonic Bio, Inc. | 43.95 Million USD | -40607.048% |
| ArriVent BioPharma, Inc. Common Stock | 74.59 Million USD | -23887.634% |
| AN2 Therapeutics, Inc. | 69.63 Million USD | -25594.516% |
| Anixa Biosciences, Inc. | 11.06 Million USD | -161675.552% |
| Vertex Pharmaceuticals Incorporated | 4.77 Billion USD | -274.709% |
| Denali Therapeutics Inc. | 527.23 Million USD | -3293.657% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -206589.043% |
| Veru Inc. | 101.34 Million USD | -17554.37% |
| Corvus Pharmaceuticals, Inc. | 23.4 Million USD | -76340.279% |
| Cingulate Inc. | 22.75 Million USD | -78516.053% |
| Passage Bio, Inc. | 108.38 Million USD | -16407.557% |
| Context Therapeutics Inc. | 25.07 Million USD | -71262.222% |
| Exicure, Inc. | 14.07 Million USD | -127012.646% |
| Day One Biopharmaceuticals, Inc. | 206.06 Million USD | -8582.922% |
| Oramed Pharmaceuticals Inc. | 43.3 Million USD | -41220.93% |
| Scinai Immunotherapeutics Ltd. | 9.17 Million USD | -194863.611% |
| Rhythm Pharmaceuticals, Inc. | 252.48 Million USD | -6986.567% |
| Nuvalent, Inc. | 149.49 Million USD | -11868.785% |
| ABVC BioPharma, Inc. | 8.06 Million USD | -221699.843% |
| Carisma Therapeutics, Inc. | 103.65 Million USD | -17162.302% |
| Unicycive Therapeutics, Inc. | 21.44 Million USD | -83318.229% |
| OmniAb, Inc. | 83.89 Million USD | -21227.107% |
| Anew Medical, Inc. | 1.3 Million USD | -1375346.807% |
| Fennec Pharmaceuticals Inc. | 32.76 Million USD | -54509.864% |
| Lipocine Inc. | 15.08 Million USD | -118548.615% |
| Lexeo Therapeutics, Inc. Common Stock | 68.51 Million USD | -26015.301% |
| Nautilus Biotechnology, Inc. | 76.15 Million USD | -23395.609% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -44282.195% |
| G1 Therapeutics, Inc. | 114.84 Million USD | -15479.858% |
| Bellerophon Therapeutics, Inc. | 22.38 Million USD | -79833.774% |
| Sage Therapeutics, Inc. | 664.14 Million USD | -2594.047% |
| Ocugen, Inc. | 71.56 Million USD | -24900.875% |
| Mind Medicine (MindMed) Inc. | 93.86 Million USD | -18961.615% |
| Q32 Bio Inc. | 92.68 Million USD | -19205.542% |
| Brainstorm Cell Therapeutics Inc. | 21.17 Million USD | -84401.634% |
| Alumis Inc. Common Stock | 158.17 Million USD | -11211.831% |
| Equillium, Inc. | 50.6 Million USD | -35256.234% |
| Kyverna Therapeutics, Inc. | 62.4 Million USD | -28570.923% |
| Coya Therapeutics, Inc. | 13.9 Million USD | -128570.707% |
| CNS Pharmaceuticals, Inc. | 18.86 Million USD | -94743.751% |
| Galera Therapeutics, Inc. | 46.95 Million USD | -38008.615% |
| Evelo Biosciences, Inc. | 108.46 Million USD | -16395.838% |
| Comera Life Sciences Holdings, Inc. | 12.39 Million USD | -144278.037% |
| Dominari Holdings Inc. | 23.83 Million USD | -74967.657% |
| Edesa Biotech, Inc. | 9.22 Million USD | -193902.445% |
| vTv Therapeutics Inc. | 11.9 Million USD | -150167.708% |
| Bio-Techne Corporation | 563.03 Million USD | -3077.822% |
| Agios Pharmaceuticals, Inc. | 408.8 Million USD | -4276.74% |
| Harmony Biosciences Holdings, Inc. | 268.75 Million USD | -6557.48% |
| Prelude Therapeutics Incorporated | 132.27 Million USD | -13426.445% |
| Candel Therapeutics, Inc. | 14.41 Million USD | -124057.768% |
| iTeos Therapeutics, Inc. | 163.69 Million USD | -10830.246% |
| Nkarta, Inc. | 131.65 Million USD | -13490.867% |
| BioCardia, Inc. | 12.12 Million USD | -147514.685% |
| Iterum Therapeutics plc | 47.46 Million USD | -37593.554% |